| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.1M | — | -34.2% |
| Cost of Revenue | $3.9M | — | -52.8% |
| Gross Profit | $4.2M | — | +4.3% |
| R&D Expense | $817K | — | -39.8% |
| SG&A Expense | $2.4M | — | +3.3% |
| Operating Income | -$671K | — | +65.5% |
| Pre-tax Income | -$363K | — | +81.0% |
| Net Income | -$520K | — | +74.2% |
| EPS (Basic) | -$0.02 | — | +77.8% |
| EPS (Diluted) | -$0.02 | — | +77.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $24.3M | -21.9% | +274.5% |
| Short-term Investments | $10.0M | — | +282.9% |
| Accounts Receivable | $5.3M | -54.0% | -26.7% |
| Inventory | $6.8M | +24.8% | -55.2% |
| Current Assets | $49.4M | -2.8% | +51.3% |
| Total Assets | $51.2M | -3.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Capital Expenditures | $15K | — | +17.3% |
| +37.9% |
| Current Liabilities | $4.6M | -16.5% | -51.4% |
| Total Liabilities | $5.8M | -14.4% | -47.2% |
| Stockholders' Equity | $45.3M | -1.5% | +74.0% |